<DOC>
	<DOCNO>NCT00149253</DOCNO>
	<brief_summary>Taken together , study value pre-emptive analgesia inconclusive . This randomized , double-blind , dose-ranging , placebo-controlled study therefore design test reduction post-operative morphine consumption achieve single-dose etoricoxib induction anesthesia .</brief_summary>
	<brief_title>Pre-Emptive Analgesia Efficacy Etoricoxib Postoperative Pain</brief_title>
	<detailed_description>Patients undergoing transabdominal hysterectomy randomize group take single dose ( orally ) etoricoxib 120 mg ( n = 18 ) , etoricoxib 180 mg ( n = 17 ) placebo ( n = 15 ) 2 hour surgery standardize general anesthesia . At post-anesthetic care unit , intravenous morphine titration give start self-controlled analgesia ( PCA ) device . Morphine consumption , pain relief score , sedative score , global evaluation score , side-effects record 1 , 2 , 4 , 8 24 h post-operatively . The primary end point morphine consumption within 24-hr post-operatively total pain relief 8 h ( TOPAR8 ) . Patient global satisfaction also assess .</detailed_description>
	<mesh_term>Etoricoxib</mesh_term>
	<criteria>The ASA I II patient undergo elective transabdominal hysterectomy general anesthesia Patients history opioid addiction chronic pain Allergy nonsteroidal antiinflammatory , asthma Concomitant use tricyclic antidepressant , opioid analgesic , antihistamine , tranquilizer , hypnotic , sedative , systemic corticosteroid Those unable understand principle patientcontrolled analgesia ( PCA ) device exclude study</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2004</verification_date>
	<keyword>Abdominal hysterectomy ,</keyword>
	<keyword>Etoricoxib ,</keyword>
	<keyword>morphine consumption ,</keyword>
	<keyword>pre-emptive analgesia</keyword>
</DOC>